𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load

✍ Scribed by Akihito Tsubota; Yasuji Arase; Fumitaka Suzuki; Yoshiyuki Suzuki; Norio Akuta; Tetsuya Hosaka; Takashi Someya; Masahiro Kobayashi; Satoshi Saitoh; Kenji Ikeda; Hiromitsu Kumada

Publisher
Springer Japan
Year
2004
Tongue
English
Weight
174 KB
Volume
39
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Early viral kinetics and treatment outco
Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naΓ―ve patients infected with hepatitis C virus of genotype 1b and high viral load
✍ Akihito Tsubota; Yasuji Arase; Takashi Someya; Yoshiyuki Suzuki; Fumitaka Suzuki πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 138 KB πŸ‘ 2 views

## Abstract An investigation was carried out to determine whether early viral monitoring could predict efficiently the virological response to combination therapy of two different regimens in treatment‐naΓ―ve chronic hepatitis C patients infected with genotype 1b with high baseline viral load. Patie

Predictive factors of virological non-re
Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load
✍ Norio Akuta; Fumitaka Suzuki; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; T πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 1 views

## Abstract Patients with high viral load (β‰₯1.0 × 10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the

Predictors of viral kinetics to peginter
Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
✍ Norio Akuta; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Yo πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 1 views

## Abstract For chronic hepatitis C virus (HCV) infection, evaluation of response to peginterferon (PEG‐IFN) plus ribavirin (RBV) therapy based on viral kinetics is useful as an early predictor of treatment efficacy, but the underlying mechanisms of the different viral kinetics to treatment are sti

Chemiluminescence enzyme immunoassay for
Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-Ξ±2b and ribavirin therapy in patients with genotype 1 and high viral loads
✍ Masaru Enomoto; Shuhei Nishiguchi; Akihiro Tamori; Modoka Kohmoto; Daiki Habu; H πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 1 views

## Abstract This study evaluated an updated chemiluminescence enzyme immunoassay (CLEIA) for hepatitis C virus (HCV) core protein for monitoring viral kinetics during treatment with interferon (IFN)‐α and ribavirin. Using the CLEIA, serum levels of HCV core protein were measured in 17 patients with

Prediction of response to peginterferon-
Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b
✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 174 KB πŸ‘ 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v